Drug Overdoses Hit a Record High in 2017

Fentanyl and other synthetic opioids are driving the increase.

Kelli Lane and Mary Randol grieve the loss of Randol's son, Dustin Billings, to an overdose in Indiana.Don Knight/The Herald-Bulletin/AP

For indispensable reporting on the coronavirus crisis, the election, and more, subscribe to the Mother Jones Daily newsletter.

The number of deaths from drug overdoses reached a record high of 72,000 in 2017, a 10 percent rise from the previous year, according to new provisional estimates form the Centers for Disease Control and Prevention.


The increase was driven by the prevalence of fentanyl and other potent synthetic opioids, which were involved in roughly 30,000 overdoses overdose deaths. (That number is likely an underestimate given the regional differences in how drug deaths are reported.)

The epidemic has put strain on virtually every sphere of the public sector, including police departments, coroner’s offices, public health agencies, and foster care systems. States are tapping into the $1 billion in federal funding available for prevention and treatment, but many say that that there’s not nearly enough money to address a crisis that costs hundreds of billions of dollars annually.

My heart sank to see the huge percentage rises in hard-hit states like Ohio and West Virginia,” said Keith Humphreys, a Stanford psychiatry professor who advised Presidents Bush and Obama on drug policy. “That region already had such high overdose rates that it takes many more additional deaths to make them rise than it would for a state with a lower base.”

However, drug policy experts are cautiously optimistic about some of the new numbers. Though overdose deaths jumped, they rose more slowly than in previous years. (Between 2015 and 2016, there was a roughly 20 percent rise in overdoses.) And in some states, the number of overdoses fell—including Massachusetts, which has long been hit hard by the scourge of heroin and fentanyl. The slowing of deaths in Massachusetts may be due to the state’s multi-pronged response: It has poured resources into increasing access to evidence-based treatment and overdose reversal drug naloxone, as well as restricting the opioids in circulation. But because the country lacks accurate data on the number of Americans addicted to opioids, it’s difficult to know which strategies are working, notes Dr. Dan Ciccarone, an epidemiologist at University of California-San Francisco. 

Ciccarone suspects that the epidemic will slowly level off and decrease over time. “I don’t think we’re going to see a rapid turnaround, because we haven’t—certainly not centrally or nationally—done enough,” he says. “We’re still hoping and praying and expecting the federal government to step in because we’re really in need of greater resources in a lot of these poor areas.”

This article has been updated.

DOES IT FEEL LIKE POLITICS IS AT A BREAKING POINT?

Headshot of Editor in Chief of Mother Jones, Clara Jeffery

It sure feels that way to me, and here at Mother Jones, we’ve been thinking a lot about what journalism needs to do differently, and how we can have the biggest impact.

We kept coming back to one word: corruption. Democracy and the rule of law being undermined by those with wealth and power for their own gain. So we're launching an ambitious Mother Jones Corruption Project to do deep, time-intensive reporting on systemic corruption, and asking the MoJo community to help crowdfund it.

We aim to hire, build a team, and give them the time and space needed to understand how we got here and how we might get out. We want to dig into the forces and decisions that have allowed massive conflicts of interest, influence peddling, and win-at-all-costs politics to flourish.

It's unlike anything we've done, and we have seed funding to get started, but we're looking to raise $500,000 from readers by July when we'll be making key budgeting decisions—and the more resources we have by then, the deeper we can dig. If our plan sounds good to you, please help kickstart it with a tax-deductible donation today.

Thanks for reading—whether or not you can pitch in today, or ever, I'm glad you're with us.

Signed by Clara Jeffery

Clara Jeffery, Editor-in-Chief

payment methods

We Recommend

Latest